Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article (51)

Advertisement

Research Article Free access | 10.1172/JCI115809

Adrenergic mechanisms contribute to the late phase of hypoglycemic glucose counterregulation in humans by stimulating lipolysis.

C G Fanelli, P De Feo, F Porcellati, G Perriello, E Torlone, F Santeusanio, P Brunetti, and G B Bolli

Istituto di Medicina Interna e Scienze Endocrine e Metaboliche, Università di Perugia, Italy.

Find articles by Fanelli, C. in: JCI | PubMed | Google Scholar

Istituto di Medicina Interna e Scienze Endocrine e Metaboliche, Università di Perugia, Italy.

Find articles by De Feo, P. in: JCI | PubMed | Google Scholar

Istituto di Medicina Interna e Scienze Endocrine e Metaboliche, Università di Perugia, Italy.

Find articles by Porcellati, F. in: JCI | PubMed | Google Scholar

Istituto di Medicina Interna e Scienze Endocrine e Metaboliche, Università di Perugia, Italy.

Find articles by Perriello, G. in: JCI | PubMed | Google Scholar

Istituto di Medicina Interna e Scienze Endocrine e Metaboliche, Università di Perugia, Italy.

Find articles by Torlone, E. in: JCI | PubMed | Google Scholar

Istituto di Medicina Interna e Scienze Endocrine e Metaboliche, Università di Perugia, Italy.

Find articles by Santeusanio, F. in: JCI | PubMed | Google Scholar

Istituto di Medicina Interna e Scienze Endocrine e Metaboliche, Università di Perugia, Italy.

Find articles by Brunetti, P. in: JCI | PubMed | Google Scholar

Istituto di Medicina Interna e Scienze Endocrine e Metaboliche, Università di Perugia, Italy.

Find articles by Bolli, G. in: JCI | PubMed | Google Scholar

Published June 1, 1992 - More info

Published in Volume 89, Issue 6 on June 1, 1992
J Clin Invest. 1992;89(6):2005–2013. https://doi.org/10.1172/JCI115809.
© 1992 The American Society for Clinical Investigation
Published June 1, 1992 - Version history
View PDF
Abstract

Three studies were performed on nine normal volunteers to assess whether catecholamine-mediated lipolysis contributes to counterregulation to hypoglycemia. In these three studies, insulin was intravenously infused for 8 h (0.30 mU.kg-1.min-1 from 0 to 180 min, and 0.40 mU.kg-1.min-1 until 480 min). In study I (control study), only insulin was infused; in study II (direct + indirect effects of catecholamines), propranolol and phentolamine were superimposed to insulin and exogenous glucose was infused to reproduce the same plasma glucose (PG) concentration of study I. Study III (indirect effect of catecholamines) was the same as study II, except heparin (0.2 U.kg-1.min-1 after 80 min), 10% Intralipid (1 ml.min-1 after 160 min) and variable glucose to match PG of study II, were also infused. Glucose production (HGO), glucose utilization (Rd) [3-3H]glucose, and glucose oxidation and lipid oxidation (LO) (indirect calorimetry) were determined. In all three studies, PG decreased from approximately 4.8 to approximately 2.9 mmol/liter (P = NS between studies), and plasma glycerol and FFA decreased to a nadir at 120 min. Afterwards, in study I plasma glycerol and FFA increased by approximately 75% at 480 min, but in study II they remained approximately 40% lower than in study I, whereas in study III they rebounded as in study I (P = NS). In study II, LO was lower than in study I (1.69 +/- 0.13 vs. 3.53 +/- 0.19 mumol.kg-1.min-1, P less than 0.05); HGO was also lower between 60 and 480 min (7.48 +/- 0.57 vs. 11.6 +/- 0.35 mumol.kg-1.min-1, P less than 0.05), whereas Rd was greater between 210 and 480 min (19 +/- 0.38 vs. 11.4 +/- 0.34 mumol.kg-1.min-1, respectively, P less than 0.05). In study III, LO increased to the values of study I; between 4 and 8 h, HGO increased by approximately 2.5 mumol.kg-1.min-1, and Rd decreased by approximately 7 mumol.kg-1.min-1 vs. study II. We conclude that, in a late phase of hypoglycemia, the indirect effects of catecholamines (lipolysis mediated) account for at least approximately 50% of the adrenergic contribution to increased HGO, and approximately 85% of suppressed Rd.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 2005
page 2005
icon of scanned page 2006
page 2006
icon of scanned page 2007
page 2007
icon of scanned page 2008
page 2008
icon of scanned page 2009
page 2009
icon of scanned page 2010
page 2010
icon of scanned page 2011
page 2011
icon of scanned page 2012
page 2012
icon of scanned page 2013
page 2013
Version history
  • Version 1 (June 1, 1992): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article (51)

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts